Osaic Holdings
MGX icon

Osaic Holdings’s Metagenomi Therapeutics MGX Stock Holding History

Osaic Holdings’s Portfolio MGX Stock Details MGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.87K Hold
2,891
– – ﹤0.01% 6805
2025
Q4 		$4.68K Sell
2,891
-250
-8% -$541 ﹤0.01% 6743
2025
Q3 		$6.29K Sell
3,141
-44
-1% -$89 ﹤0.01% 6623
2025
Q2 		$4.71K Buy
3,185
+44
+1% +$69 ﹤0.01% 6570
2025
Q1 		$4.27K Buy
3,141
+1,672
+114% +$3.98K ﹤0.01% 6264
2024
Q4 		$5.3K Hold
1,469
– – ﹤0.01% 6158
2024
Q3 		$3.19K Buy
+1,469
New +$5.1K ﹤0.01% 6409

Other funds holding MGX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings's MGX Position: Q1 2026 in Review

Osaic Holdings held its Metagenomi Therapeutics (MGX) position steady in Q1 2026 at 2,891 shares worth $3.87K. The position accounts for ﹤0.01% of the portfolio, ranked #6805.

Osaic Holdings first reported a position in MGX in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.29K in Q3 2025. 48 funds tracked by Wall St. Rank hold MGX as of Q1 2026.

  • Osaic Holdings held 2,891 shares of Metagenomi Therapeutics worth $3.87K as of Q1 2026.
  • Osaic Holdings left its Metagenomi Therapeutics share count unchanged in Q1 2026.
  • Metagenomi Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6805 holding.
  • Osaic Holdings first reported a position in Metagenomi Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Osaic Holdings's Metagenomi Therapeutics position peaked at $6.29K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held Metagenomi Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.